236 related articles for article (PubMed ID: 7490814)
1. Intracorporeal phenylephrine in the treatment of priapism.
Muruve N; Hosking DH
J Urol; 1996 Jan; 155(1):141-3. PubMed ID: 7490814
[TBL] [Abstract][Full Text] [Related]
2. The incidence and management of priapism in Western Australia: a 16 year audit.
Earle CM; Stuckey BG; Ching HL; Wisniewski ZS
Int J Impot Res; 2003 Aug; 15(4):272-6. PubMed ID: 12934055
[TBL] [Abstract][Full Text] [Related]
3. [Methylene blue: an effective therapeutic alternative for priapism induced by intracavernous injection of vasoactive agents].
Martínez Portillo FJ; Fernández Arancibia MI; Bach S; Alken P; Jünemann KP
Arch Esp Urol; 2002 Apr; 55(3):303-8. PubMed ID: 12068762
[TBL] [Abstract][Full Text] [Related]
4. Chart for preparation of dilutions of alpha-adrenergic agonists for intracavernous use in treatment of priapism.
Lee M; Cannon B; Sharifi R
J Urol; 1995 Apr; 153(4):1182-3. PubMed ID: 7869493
[TBL] [Abstract][Full Text] [Related]
5. Treatment of pharmacological priapism with phenylephrine.
Dittrich A; Albrecht K; Bar-Moshe O; Vandendris M
J Urol; 1991 Aug; 146(2):323-4. PubMed ID: 1856926
[TBL] [Abstract][Full Text] [Related]
6. Oral midodrine for prostaglandin e1 induced priapism in spinal cord injured patients.
Soler JM; Previnaire JG; Mieusset R; Plante P
J Urol; 2009 Sep; 182(3):1096-100. PubMed ID: 19616810
[TBL] [Abstract][Full Text] [Related]
7. [Metaraminol--an antidote in corpus cavernosum autoinjection therapy-induced prolonged erection].
Stief CG; Gilbert P; Wetterhauer U; Bähren W; Thon W; Altwein JE
Urologe A; 1986 May; 25(3):164-5. PubMed ID: 2426857
[TBL] [Abstract][Full Text] [Related]
8. Priapism following ingestion of papaverine tablets.
Prasad K; el-Sherif A
Scand J Urol Nephrol; 1996 Dec; 30(6):515-6. PubMed ID: 9008039
[TBL] [Abstract][Full Text] [Related]
9. [Topical therapy in erectile dysfunction].
Floth A
Wien Med Wochenschr; 2000; 150(1-2):14-7. PubMed ID: 10746290
[TBL] [Abstract][Full Text] [Related]
10. A prospective randomized study to optimize the dosage of trimix ingredients and compare its efficacy and safety with prostaglandin E1.
Seyam R; Mohamed K; Akhras AA; Rashwan H
Int J Impot Res; 2005; 17(4):346-53. PubMed ID: 15772683
[TBL] [Abstract][Full Text] [Related]
11. Effects of priapism lasting 24 hours or longer caused by intracavernosal injection of vasoactive drugs.
Kulmala RV; Tamella TL
Int J Impot Res; 1995 Jun; 7(2):131-6. PubMed ID: 7496442
[TBL] [Abstract][Full Text] [Related]
12. Oral terbutaline in the management of pharmacologically induced prolonged erection.
Priyadarshi S
Int J Impot Res; 2004 Oct; 16(5):424-6. PubMed ID: 14999218
[TBL] [Abstract][Full Text] [Related]
13. Management of pharmacologically induced prolonged penile erection with oral terbutaline in traumatic paraplegics.
Soni BM; Vaidyanathan S; Krishnan KR
Paraplegia; 1994 Oct; 32(10):670-4. PubMed ID: 7831073
[TBL] [Abstract][Full Text] [Related]
14. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
Asuar Aydillo S
Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
[No Abstract] [Full Text] [Related]
15. Priapism associated with concurrent use of phosphodiesterase inhibitor drugs and intracavernous injection therapy.
McMahon CG
Int J Impot Res; 2003 Oct; 15(5):383-4. PubMed ID: 14562142
[No Abstract] [Full Text] [Related]
16. Methylene blue as a means of treatment for priapism caused by intracavernous injection to combat erectile dysfunction.
Hübler J; Szántó A; Könyves K
Int Urol Nephrol; 2003; 35(4):519-21. PubMed ID: 15198160
[TBL] [Abstract][Full Text] [Related]
17. [Priapism following intracavernous injection of vasoactive substances as a urologic emergency].
Papadopoulos I; Weichert-Jacobsen K; Wand H
Z Urol Nephrol; 1990 May; 83(5):233-7. PubMed ID: 2392883
[TBL] [Abstract][Full Text] [Related]
18. Injection therapy for impotence.
Kursh ED; Bodner DR; Resnick MI; Althof SE; Turner L; Risen C; Levine SB
Urol Clin North Am; 1988 Nov; 15(4):625-9. PubMed ID: 3055615
[TBL] [Abstract][Full Text] [Related]
19. Intracavernosal adrenalin injection in priapism.
Keskin D; Cal C; Delibaş M; Ozyurt C; Günaydin G; Nazli O; Cüreklibatir I
Int J Impot Res; 2000 Dec; 12(6):312-4. PubMed ID: 11416834
[TBL] [Abstract][Full Text] [Related]
20. The prediction of papaverine induced priapism by color Doppler sonography.
Secil M; Arslan D; Goktay AY; Esen AA; Dicle O; Pirnar T
J Urol; 2001 Feb; 165(2):416-8. PubMed ID: 11176386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
